International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2023   Volume 13   Issue 6

Dissolution Rate Enhancement of Dolutegravir Sodium Through Nanosuspension Technology Using 32 Factorial Design
Download PDF


,
Citation
Vancouver
Rodriques PB, Gopalbhai PB. Dissolution Rate Enhancement of Dolutegravir Sodium Through Nanosuspension Technology Using 32 Factorial Design. Int J Pharm Phytopharmacol Res. 2023;13(6):1-7. https://doi.org/10.51847/1wNkc9fDrX
APA
Rodriques, P. B., & Gopalbhai, P. B. (2023). Dissolution Rate Enhancement of Dolutegravir Sodium Through Nanosuspension Technology Using 32 Factorial Design. International Journal of Pharmaceutical And Phytopharmacological Research, 13(6), 1-7. https://doi.org/10.51847/1wNkc9fDrX
Download citation:   EndNote   RIS
Article Link:
Downloads: 480
Views: 2661
Abstract

Dolutegravir Sodium is a potent antiretroviral medication used in the treatment of HIV. It is BCS Class II compound and is practically insoluble at normal gastric pH range.  The research aimed to discover and optimize operational and formulation factors that affect the characteristics of the drug. 32 factorial design was utilized for the investigation. PVP K30, Polyvinyl Alcohol, Polxammer 407, and Polxammer 188 were used in preparation of nanosupension. The formulation variables tested were the polymer concentration, whereas the manufacturing variable was homogenization speed. Particle size and saturation solubility were two responses that were assessed in this investigation. The results of the analysis of variance show that the polymer concentration and homogenization speed significantly impact the saturation solubility and particle size of the nanosuspension. The contour plot and resulting polynomial formula assist in estimating the values of chosen independent factors to develop the best nanosuspension formulations with the required characteristics.

Volume 15
Issue 1
2025

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2024 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.